For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
Global Warming Apathy, Pelosi on Oil Drilling and Government Health Care
A new survey suggests that public concern about global warming is on the decline. House Speaker Nancy Pelosi reverses her opposition to a vote on…
Study
FDA’s Bad Medicine
How the dispersed knowledge problem affects drug safety analysis and how markets and technology will help patients…
Blog
Ending the HIV Travel Ban
The federal government is finally in the process of lifting the travel ban on individuals who are HIV positive. For many years, one of…
Newsletter
Losses at Fannie Mae, Satellite TV Merger and Toxic Chemicals
Mortgage giant Fannie Mae reports a loss of $2.3 billion. Cable TV provider Dish Network proposes a merger with DirecTV. Former New York Times environmental…
Newsletter
Global Warming Allergies, Change at the SEC and Accounting for the Cost of Government
Global warming gets blamed for an increase in allergies. Paul Atkins steps down as Commissioner of the U.S. Securities and Exchange Commission. Taxpayer advocates observe…
Newsletter
Costs of Regulation, FDA Reform and Global Warming Skepticism
The House Small Business Committee hears testimony on the costs of federal regulation. Patient advocates urge lawmakers to pass legislation forcing the Food and Drug…